Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 138

1.

Levels of Circulating Intermediate Monocytes Decrease after Aortic Valve Replacement in Patients with Severe Aortic Stenosis.

Hewing B, Ellerbroek R, Au SC, Stangl V, Dreger H, Laule M, Grubitzsch H, Knebel F, Baumann G, Ludwig A, Stangl K.

Thromb Haemost. 2017 Dec;117(12):2346-2355. doi: 10.1160/TH17-05-0341. Epub 2017 Dec 6. No abstract available.

PMID:
29212122
2.

Right heart function in impaired left ventricular diastolic function: 2D speckle tracking echocardiography-based and Doppler tissue imaging-based analysis of right atrial and ventricular function.

Brand A, Bathe M, Oertelt-Prigione S, Seeland U, Rücke M, Regitz-Zagrosek V, Stangl K, Knebel F, Stangl V, Dreger H.

Echocardiography. 2017 Nov 6. doi: 10.1111/echo.13745. [Epub ahead of print]

PMID:
29106754
3.

Immunoproteasome subunit ß5i/LMP7-deficiency in atherosclerosis.

Hewing B, Ludwig A, Dan C, Pötzsch M, Hannemann C, Petry A, Lauer D, Görlach A, Kaschina E, Müller DN, Baumann G, Stangl V, Stangl K, Wilck N.

Sci Rep. 2017 Oct 17;7(1):13342. doi: 10.1038/s41598-017-13592-w.

4.

Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.

Hilfiker-Kleiner D, Haghikia A, Berliner D, Vogel-Claussen J, Schwab J, Franke A, Schwarzkopf M, Ehlermann P, Pfister R, Michels G, Westenfeld R, Stangl V, Kindermann I, Kühl U, Angermann CE, Schlitt A, Fischer D, Podewski E, Böhm M, Sliwa K, Bauersachs J.

Eur Heart J. 2017 Sep 14;38(35):2671-2679. doi: 10.1093/eurheartj/ehx355.

PMID:
28934837
5.

Tea-induced improvement of endothelial function in humans: No role for epigallocatechin gallate (EGCG).

Lorenz M, Rauhut F, Hofer C, Gwosc S, Müller E, Praeger D, Zimmermann BF, Wernecke KD, Baumann G, Stangl K, Stangl V.

Sci Rep. 2017 May 23;7(1):2279. doi: 10.1038/s41598-017-02384-x.

6.

The Effect of Low-Dose Proteasome Inhibition on Pre-Existing Atherosclerosis in LDL Receptor-Deficient Mice.

Wilck N, Fechner M, Dan C, Stangl V, Stangl K, Ludwig A.

Int J Mol Sci. 2017 Apr 7;18(4). pii: E781. doi: 10.3390/ijms18040781.

7.

Inflammation-induced brain endothelial activation leads to uptake of electrostatically stabilized iron oxide nanoparticles via sulfated glycosaminoglycans.

Berndt D, Millward JM, Schnorr J, Taupitz M, Stangl V, Paul F, Wagner S, Wuerfel JT, Sack I, Ludwig A, Infante-Duarte C.

Nanomedicine. 2017 May;13(4):1411-1421. doi: 10.1016/j.nano.2017.01.010. Epub 2017 Jan 25.

PMID:
28131884
8.

Severe Aortic Valve Stenosis in Adults is Associated with Increased Levels of Circulating Intermediate Monocytes.

Hewing B, Au SC, Ludwig A, Ellerbroek R, van Dijck P, Hartmann L, Grubitzsch H, Giannini C, Laule M, Stangl V, Baumann G, Stangl K.

J Cardiovasc Transl Res. 2017 Feb;10(1):27-34. doi: 10.1007/s12265-016-9726-9. Epub 2017 Jan 17.

PMID:
28097522
9.

Pregnancy and cardiovascular risk: A review focused on women with heart disease undergoing fertility treatment.

Rossberg N, Stangl K, Stangl V.

Eur J Prev Cardiol. 2016 Dec;23(18):1953-1961. doi: 10.1177/2047487316673143. Epub 2016 Oct 17. Review.

PMID:
27798362
10.

Prevalence of arterial stiffness and the risk of myocardial diastolic dysfunction in women.

Seeland U, Brecht A, Nauman AT, Oertelt-Prigione S, Ruecke M, Knebel F, Stangl V, Regitz-Zagrosek V.

Biosci Rep. 2016 Oct 27;36(5). pii: e00400. Print 2016 Oct.

11.

Copeptin, resistant hypertension and renal sympathetic denervation.

Schwerg M, Slagman A, Stangl K, Stangl V.

Biomarkers. 2017 May - Jun;22(3-4):311-314. doi: 10.1080/1354750X.2016.1252968. Epub 2016 Nov 8.

PMID:
27775435
12.

Mid-regional pro-adrenomedullin (MR-proADM) and mid-regional pro-atrial natriuretic peptide (MR-proANP) in severe aortic valve stenosis: association with outcome after transcatheter aortic valve implantation (TAVI).

Baldenhofer G, Laule M, Mockel M, Sanad W, Knebel F, Dreger H, Leonhardt F, Sander M, Grubitzsch H, Baumann G, Stangl K, Stangl V.

Clin Chem Lab Med. 2017 Feb 1;55(2):275-283. doi: 10.1515/cclm-2015-0419.

PMID:
27522619
13.

Magnetic Particle Spectroscopy Reveals Dynamic Changes in the Magnetic Behavior of Very Small Superparamagnetic Iron Oxide Nanoparticles During Cellular Uptake and Enables Determination of Cell-Labeling Efficacy.

Poller WC, Löwa N, Wiekhorst F, Taupitz M, Wagner S, Möller K, Baumann G, Stangl V, Trahms L, Ludwig A.

J Biomed Nanotechnol. 2016 Feb;12(2):337-46.

PMID:
27305767
14.

Galectin-3 and prediction of therapeutic response to renal sympathetic denervation.

Schwerg M, Eilers B, Wienecke A, Baumann G, Laule M, Knebel F, Stangl K, Stangl V.

Clin Exp Hypertens. 2016;38(4):399-403. doi: 10.3109/10641963.2016.1148157. Epub 2016 May 9.

PMID:
27159890
15.

Left Atrial Function in Preclinical Diastolic Dysfunction: Two-Dimensional Speckle-Tracking Echocardiography-Derived Results from the BEFRI Trial.

Brecht A, Oertelt-Prigione S, Seeland U, Rücke M, Hättasch R, Wagelöhner T, Regitz-Zagrosek V, Baumann G, Knebel F, Stangl V.

J Am Soc Echocardiogr. 2016 Aug;29(8):750-758. doi: 10.1016/j.echo.2016.03.013. Epub 2016 May 4.

PMID:
27156904
16.

Biomarker response and therapy prediction in renal denervation therapy - the role of MR-proadrenomedullin in a multicenter approach.

Neumann JT, Schwerg M, Dörr O, Mortensen K, Franzen K, Zeller T, Ojeda F, Blankenberg S, Hamm C, Nef H, Stangl V, Möckel M, Sydow K.

Biomarkers. 2017 May - Jun;22(3-4):225-231. doi: 10.3109/1354750X.2016.1172112. Epub 2016 May 6.

PMID:
27153479
17.

Human Umbilical Vein Endothelial Cells foster conversion of CD4+CD25-Foxp3- T cells into CD4+Foxp3+ Regulatory T Cells via Transforming Growth Factor-β.

Oettel A, Lorenz M, Stangl V, Costa SD, Zenclussen AC, Schumacher A.

Sci Rep. 2016 Mar 18;6:23278. doi: 10.1038/srep23278.

18.

Epigenetic suppression of iNOS expression in human endothelial cells: A potential role of Ezh2-mediated H3K27me3.

Dreger H, Ludwig A, Weller A, Baumann G, Stangl V, Stangl K.

Genomics. 2016 Apr;107(4):145-9. doi: 10.1016/j.ygeno.2016.02.002. Epub 2016 Feb 4.

PMID:
26853880
19.

Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes.

EUGenMed Cardiovascular Clinical Study Group, Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E, Franconi F, Gerdts E, Foryst-Ludwig A, Maas AH, Kautzky-Willer A, Knappe-Wegner D, Kintscher U, Ladwig KH, Schenck-Gustafsson K, Stangl V.

Eur Heart J. 2016 Jan 1;37(1):24-34. doi: 10.1093/eurheartj/ehv598. Epub 2015 Nov 3. Review. No abstract available.

PMID:
26530104
20.

Staged Catheter-Based Valve Treatment of Severe Carcinoid Heart Disease.

Laule M, Pschowski R, Pape UF, Pavel M, Stangl V, Baumann G, Wiedenmann B, Stangl K.

Neuroendocrinology. 2016;103(3-4):259-62. doi: 10.1159/000437167. Epub 2015 Jun 30.

PMID:
26138598

Supplemental Content

Loading ...
Support Center